Sandra Lee is a partner in the Intellectual Property Practice in the firm’s New York office. She has a broad range of experience in domestic and foreign patent procurement of utility and design patents, post-grant proceedings, client counseling and strategic portfolio management. Ms. Lee’s work is focused in the pharmaceutical, chemical, medical device and consumer products areas.
Ms. Lee also counsels her clients in Orange Book and Hatch-Waxman related issues, and is involved in pharmaceutical litigation matters from pre-suit investigation and continuing through trial. Ms. Lee has focused primarily on pharmaceutical litigation related to Hatch-Waxman.
Ms. Lee also has vast experience with due diligence investigations on proposed transactions across a broad range of technologies, and assists her clients with IP-related agreements associated with technology transfers through acquisition or licensing opportunities. Ms. Lee also conducts freedom to operate and clearance investigations, validity/infringement assessments, and investigates inventorship disputes.
Prior to her legal career, Ms. Lee was in biomedical research in the Department of Anesthesia at the Brigham & Women’s Hospital in Boston.
- Major pharmaceutical companies
- Start-up biopharmaceutical companies
- Value-added specialty products manufacturers
- Consumer products companies
- University clients
- Chemical development and processing manufacturers
Awards & Community
Listed in Who's Who Legal: Life Sciences, 2018
Listed in International Who's Who of Life Sciences Lawyers, 2012
Recognized as a New York Super Lawyer - Rising Star, 2012
Publications, Speeches & Presentations
Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second EditionExternal Articles
Chapter 11: Post-marketing Regulatory Requirements and Life Cycle Management
Chapter 12: Continued Patent Portfolio Development before the Patent Office
Chapter 14: Pre-Litigation Investigations and Due Diligence
Intellectual Property Report